German pharmaceutical giant Bayer on Thursday updated its full-year guidance following a stronger-than-expected performance ...

Full-year 2025 net sales outlook is set at $3.3 billion to $3.4 billion or down 1% to up 1% year-over-year, below initial guidance from February, due to lower assumptions for U.S. wholesale and DTC ...